# Lynx1 Capital Management LP: Form 13F holdings

An institutional investment manager in DORADO, PR. SEC CIK 1910456.

- Quarter ended: 2026-06-30
- Filed: 2026-08-13
- Reported value: $865.5m
- Positions: 27 (27 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1910456/000191045626000004/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| GH RESEARCH PLC | ORDINARY SHARES | $356.5m | 41.2% | 13,263,288 |  | Added +2,500,000 |
| [CULLINAN THERAPEUTICS INC (CGEM)](/companies/cgem.md) | COM | $163.2m | 18.9% | 8,963,500 |  | Unchanged |
| [STOKE THERAPEUTICS INC (STOK)](/companies/stok.md) | COM | $132.1m | 15.3% | 4,038,404 |  | Reduced −725,269 |
| [AGIOS PHARMACEUTICALS INC (AGIO)](/companies/agio.md) | COM | $126.5m | 14.6% | 3,408,937 |  | Added +797,369 |
| [C4 THERAPEUTICS INC (CCCC)](/companies/cccc.md) | COM STK | $34.2m | 4.0% | 7,326,691 |  | Added +327,789 |
| [KORRO BIO INC (KRRO)](/companies/krro.md) | COM | $20.3m | 2.3% | 1,538,296 |  | Unchanged |
| [TSCAN THERAPEUTICS INC (TCRX)](/companies/tcrx.md) | COM | $7.9m | 0.9% | 8,019,148 |  | Unchanged |
| [PRECISION BIOSCIENCES INC (DTIL)](/companies/dtil.md) | COM NEW | $7.5m | 0.9% | 950,466 |  | Reduced −34,647 |
| [NEUPHORIA THERAPEUTICS INC (NEUP)](/companies/neup.md) | COM | $3.8m | 0.4% | 875,328 |  | Unchanged |
| [PASSAGE BIO INC (PASG)](/companies/pasg.md) | COM NEW | $3.3m | 0.4% | 673,759 |  | Added +50,055 |
| [CG ONCOLOGY INC (CGON)](/companies/cgon.md) | COM | $2.2m | 0.3% | 31,391 |  | Reduced −200 |
| [PLIANT THERAPEUTICS INC (PLRX)](/companies/plrx.md) | COM | $2.0m | 0.2% | 1,798,070 |  | New +1,798,070 |
| [ENTRADA THERAPEUTICS INC (TRDA)](/companies/trda.md) | COM | $1.3m | 0.2% | 178,606 |  | Reduced −33,083 |
| VYNE THERAPEUTICS INC | COM | $1.1m | 0.1% | 1,628,700 |  | Unchanged |
| PROQR THRAPEUTICS N V | SHS EURO | $969.8k | 0.1% | 521,413 |  | Added +452,927 |
| [TRAWS PHARMA INC (TRAW)](/companies/traw.md) | COM NEW | $471.8k | <0.1% | 559,470 |  | Added +544,392 |
| [FOGHORN THERAPEUTICS INC (FHTX)](/companies/fhtx.md) | COM | $300.5k | <0.1% | 61,588 |  | New +61,588 |
| [DENALI THERAPEUTICS INC (DNLI)](/companies/dnli.md) | COM | $299.8k | <0.1% | 11,658 |  | Reduced −1,868,645 |
| [XENCOR INC (XNCR)](/companies/xncr.md) | COM | $292.9k | <0.1% | 18,194 |  | Reduced −518,204 |
| [ABSCI CORPORATION (ABSI)](/companies/absi.md) | COM | $246.2k | <0.1% | 21,245 |  | Unchanged |
| [WEREWOLF THERAPEUTICS INC (HOWL)](/companies/howl.md) | COM | $236.7k | <0.1% | 657,786 |  | Unchanged |
| IMMATICS N.V | SHS | $235.4k | <0.1% | 23,236 |  | Reduced −193,737 |
| [AVALO THERAPEUTICS INC (AVTX)](/companies/avtx.md) | COM NEW | $186.6k | <0.1% | 10,100 |  | New +10,100 |
| [BOLT BIOTHERAPEUTICS INC (BOLT)](/companies/bolt.md) | COM NEW | $118.6k | <0.1% | 30,800 |  | Unchanged |
| [NUVATION BIO INC (NUVB)](/companies/nuvb.md) | COM CL A | $91.0k | <0.1% | 16,029 |  | New +16,029 |
| [EUPRAXIA PHARMACEUTICALS INC (EPRX)](/companies/eprx.md) | COM | $66.1k | <0.1% | 10,000 |  | New +10,000 |
| [INHIBIKASE THERAPEUTICS INC (IKT)](/companies/ikt.md) | COM NEW | $40.6k | <0.1% | 20,000 |  | New +20,000 |

## Sold out

Held at the end of the quarter before and not reported this quarter.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [DESIGN THERAPEUTICS INC (DSGN)](/companies/dsgn.md) | COM | $0 | 0.0% | 0 |  | Sold out −119,516 |
| [IBIO INC (IBIO)](/companies/ibio.md) | COM NEW | $0 | 0.0% | 0 |  | Sold out −68,076 |

Source: SEC EDGAR, Form 13F-HR, accession 0001910456-26-000004. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.